Roles of Kampo medicine in chemotherapy‐related adverse events

Abstract

In recent years, multidisciplinary treatment of cancer has greatly improved the results of cancer treatment. In particular, the development of molecular targeted drugs and cancer immunotherapy drugs has been carried out for many carcinomas, and this has had an important role in improving outcomes. At the same time, there have been important advances in supportive care‐related drugs, with a focus on antiemesis or neutropenia. Here, we overview the clinical roles and potential of the use and utilization of Kampo medicine.